Portfolio

GNA Biosolutions

Reinventing Molecular Diagnostics

GNA Biosolutions developed a disruptive PCA (Pulse Controlled Amplification) technology for DNA analysis from complex clinical samples. GNA’s technology delivers results within a few minutes and is therefore significantly faster and cheaper than other solutions in the field of mole­cular diagnostics. GNA’s rapid tests were also used for the diagnosis of COVID-19.

Versantis Overview cunesoft